LINCOLN PHARMACEUTICALS
Back to Cashflow Statement
|
LINCOLN PHARMACEUTICALS Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹106 Cr | ₹93 Cr | ₹63 Cr | ₹39 Cr | ₹76 Cr |
What is the latest Cash Flow from Operating Activities ratio of LINCOLN PHARMACEUTICALS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹106 Cr |
| Mar2025 | ₹93 Cr |
| Mar2024 | ₹63 Cr |
| Mar2023 | ₹39 Cr |
| Mar2022 | ₹76 Cr |
How is Cash Flow from Operating Activities of LINCOLN PHARMACEUTICALS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹106 Cr | 14.35 | |
| Mar2025 | ₹93 Cr | 47.14 | |
| Mar2024 | ₹63 Cr | 61.01 | |
| Mar2023 | ₹39 Cr | -48.43 | |
| Mar2022 | ₹76 Cr | - | |
Compare Cash Flow from Operating Activities of peers of LINCOLN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LINCOLN PHARMACEUTICALS | ₹1,026.2 Cr | 2.2% | -11.3% | -3.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,963.0 Cr | 2.7% | 1.4% | 4.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹269,451.0 Cr | 4.5% | 6.3% | 50.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,456.0 Cr | 1.8% | -1.3% | 31.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹113,664.0 Cr | 0.8% | 12.5% | 14.1% | Stock Analytics | |
| CIPLA | ₹113,246.0 Cr | 1.6% | 4.4% | -9.1% | Stock Analytics | |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LINCOLN PHARMACEUTICALS | 2.2% |
-11.3% |
-3.9% |
| SENSEX | 7% |
9.6% |
-6.7% |
You may also like the below Video Courses